SCHEMBL2904702

SCHEMBL2904702

CC(C)CCCCC(CCCCC(C)C)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 1/20 0.52
AKR1A1 P14550 1/20 0.52
CHRM3 P20309 1/20 0.52
HTR2A P28223 1/20 0.52
HTR2C P28335 1/20 0.52
ADRA1A P35348 1/20 0.52
HRH1 P35367 1/20 0.52
DRD3 P35462 1/20 0.52
SLC6A3 Q01959 1/20 0.52
HDAC1 Q13547 1/20 0.52
HDAC2 Q92769 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
BLM P54132 1/20 0.52
CA2 P00918 1/20 0.50
MAPK1 P28482 1/20 0.50
FOLH1 Q04609 6/20 0.48
SLC1A2 P43004 3/20 0.48
SLC1A1 P43005 3/20 0.48
SLC1A3 P43003 2/20 0.48
GRIK1 P39086 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5873241 0.97 FOLH1 (0.50) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL158479 0.97 FOLH1 (0.50) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL1434851 0.97 FOLH1 (0.50) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL19118487 0.97 FOLH1 (0.50) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL2212069 0.97 FOLH1 (0.50) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL2896870 0.97 FOLH1 (0.50) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL1035498 0.97 FOLH1 (0.50) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL8880115 0.97 FOLH1 (0.50) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL2211471 0.97 FOLH1 (0.50) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL2210055 0.97 FOLH1 (0.50) CHRM1AKR1A1CHRM3HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100322877-A1 SILICONE ELASTOMERS IN COSMETIC ESTERS ALZO INTERNATIONAL, INC. 2010-12-23 US claimed
EP-2211833-A2 SILICONE ELASTOMERS IN COSMETIC ESTERS Alzo International, Inc. (US) 2010-08-04 EP claimed
WO-2009054931-A2 SILICONE ELASTOMERS IN COSMETIC ESTERS ALZO INTERNATIONAL, INC. (US) 2009-04-30 WO claimed
WO-2015048228-A2 IMPROVED SILICONE ELASTOMER GELS AND RELATED HYDROSILYLATION PROCESSES ALZO INTERNATIONAL, INC. (US) 2015-04-02 WO disclosed
WO-2012135281-A2 SILICONE CROSSLINKED UNSATURATED HYDROCARBON BASED POLYMERS ALZO INTERNATIONAL, INC. (US) 2012-10-04 WO disclosed
US-20100322877-A1 SILICONE ELASTOMERS IN COSMETIC ESTERS ALZO INTERNATIONAL, INC. 2010-12-23 US disclosed
EP-2211833-A2 SILICONE ELASTOMERS IN COSMETIC ESTERS Alzo International, Inc. (US) 2010-08-04 EP disclosed
WO-2009054931-A2 SILICONE ELASTOMERS IN COSMETIC ESTERS ALZO INTERNATIONAL, INC. (US) 2009-04-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100322877-A1 SILICONE ELASTOMERS IN COSMETIC ESTERS CUTA, LAGE3, MMS19 CHRM1 3220/4885AKR1A1 2887/4885CHRM3 3028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.